You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》建銀國際降京東健康(06618.HK)目標價至43.9元 進入後疫情階段
建銀國際發表報告指,京東健康(06618.HK)去年下半年業績穩健。由於2022年第四季疫情相關的保健產品基數較高,公司去年下半年銷售額按年下降0.3%,至264億元人民幣,好過該行預期的254億元人民幣。 建銀國際對京東健康目標價由56.2元下調至43.9元。同時將2024至2026財年銷售額年複合增長率從15.9%下調至14.9%,原因是公司正在告別受疫情推動的階段,因此未來的銷售額增長將放緩。該行將 2024財年非國際財務報告準則淨利潤預測下調9.4%,因為公司的利息收入將大幅減少。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account